December 6, 2004
Health Sciences Group Acquires Polymann LicenseLOS ANGELES--Health Sciences Group Inc. acquired an exclusive worldwide license (excluding Korea) to a patented technology (U.S. Patent No. 6,747,015, addressing cholesterol reduction) through the acquisition of Polymann Technologies. Health Sciences Group acquired the company in a tax-free, stock-for-stock exchange with UTEK Corp."We believe the acquisition of Polymann complements our portfolio of value-added products and reinforces our focus on selling high-quality, proprietary products that offer a positive health benefit," said Fred Tannous, co-chairman and chief executive officer of Health Sciences Group. Polymann is a nutraceutical derived from seaweed using a patented extraction method.In additional news, Health Sciences Group announced it discontinued operations of its wholly-owned subsidiary, Quality Botanical Ingredients. According to the company, QBI's low-margin, commodity business strategy was negatively impacting company growth.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023